1. Home
  2. AIRE vs CELU Comparison

AIRE vs CELU Comparison

Compare AIRE & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIRE
  • CELU
  • Stock Information
  • Founded
  • AIRE 2021
  • CELU 2016
  • Country
  • AIRE United States
  • CELU United States
  • Employees
  • AIRE N/A
  • CELU N/A
  • Industry
  • AIRE
  • CELU Biotechnology: Pharmaceutical Preparations
  • Sector
  • AIRE
  • CELU Health Care
  • Exchange
  • AIRE Nasdaq
  • CELU Nasdaq
  • Market Cap
  • AIRE 53.2M
  • CELU 50.4M
  • IPO Year
  • AIRE N/A
  • CELU N/A
  • Fundamental
  • Price
  • AIRE $1.67
  • CELU $2.30
  • Analyst Decision
  • AIRE Strong Buy
  • CELU
  • Analyst Count
  • AIRE 1
  • CELU 0
  • Target Price
  • AIRE $3.00
  • CELU N/A
  • AVG Volume (30 Days)
  • AIRE 7.8M
  • CELU 89.6K
  • Earning Date
  • AIRE 01-24-2025
  • CELU 12-06-2024
  • Dividend Yield
  • AIRE N/A
  • CELU N/A
  • EPS Growth
  • AIRE N/A
  • CELU N/A
  • EPS
  • AIRE N/A
  • CELU N/A
  • Revenue
  • AIRE $379,241.00
  • CELU $48,200,000.00
  • Revenue This Year
  • AIRE $590.83
  • CELU N/A
  • Revenue Next Year
  • AIRE $158.84
  • CELU $233.89
  • P/E Ratio
  • AIRE N/A
  • CELU N/A
  • Revenue Growth
  • AIRE 18.11
  • CELU 225.94
  • 52 Week Low
  • AIRE $0.53
  • CELU $1.30
  • 52 Week High
  • AIRE $4.49
  • CELU $7.97
  • Technical
  • Relative Strength Index (RSI)
  • AIRE 50.22
  • CELU 52.94
  • Support Level
  • AIRE $1.68
  • CELU $2.04
  • Resistance Level
  • AIRE $1.92
  • CELU $2.39
  • Average True Range (ATR)
  • AIRE 0.36
  • CELU 0.17
  • MACD
  • AIRE -0.09
  • CELU 0.02
  • Stochastic Oscillator
  • AIRE 9.11
  • CELU 70.76

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company that develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability; and has an app for investment into the properties that it purchased aimed at retail investors. The company's reportable segments are; Platform Services, which derives key revenue, and the Rental business segment.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.

Share on Social Networks: